Evidence map›Paper›PMID 31057559›Full record

ReviewFrontiers in immunology2019

Immune Checkpoint Molecules in Reproductive Immunology.

Eva Miko, Matyas Meggyes, Katalin Doba, Aliz Barakonyi, Laszlo Szereday

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 95 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Differential Immune Checkpoint Expression in CD4International journal of molecular sciences · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Immunological Profiling of CD8International journal of molecular sciences · 2024
    Article
  11. Article
  12. Review
  13. Pregnancy and the Autoimmune Patient.Current allergy and asthma reports · 2024
    Review
  14. Article
  15. Immunologic aspects of preeclampsia.AJOG global reports · 2024
    Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Eva MikoDepartment of Medical Microbiology and Immunology, Medical School, University of Pécs, Pécs, Hungary.
Matyas MeggyesDepartment of Medical Microbiology and Immunology, Medical School, University of Pécs, Pécs, Hungary.
Katalin DobaDepartment of Medical Microbiology and Immunology, Medical School, University of Pécs, Pécs, Hungary.
Aliz BarakonyiDepartment of Medical Microbiology and Immunology, Medical School, University of Pécs, Pécs, Hungary.
Laszlo SzeredayDepartment of Medical Microbiology and Immunology, Medical School, University of Pécs, Pécs, Hungary.
University of Pecs · HUSzent János Kórház · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immune checkpoint molecules, like CTLA-4, TIM-3, PD-1, are negative regulators of immune responses to avoid immune injury. Checkpoint regulators are thought to actively participate in the immune defense of infections, prevention of autoimmunity, transplantation, and tumor immune evasion. Maternal-fetal immunotolerance represents a real immunological challenge for the immune system of the mother: beside acceptance of the semiallogeneic fetus, the maternal immune system has to be prepared for immune defense mostly against infections. In this particular situation, the role of immune checkpoint molecules could be of special interest. In this review, we describe current knowledge on the role of immune checkpoint molecules in reproductive immunology.

Indexed as

AnimalsHumansImmune ToleranceImmunityMaternal-Fetal RelationsCTLA-4immune checkpoint moleculeimmunotolerancePD-1pregnancyreproductive immunologyTIM-3

Identifiers

PMID31057559
PMCPMC6482223
OpenAlexW2938944469

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.